BioRealm

BioRealm operates as a specialized service provider and product developer in the genomics and data science space, serving academic, government, and industry clients. The company's core expertise lies in applying advanced statistical methods, including Bayesian analysis and machine learning, to complex genetic and multi-omics data across a wide range of therapeutic areas. Its most significant proprietary asset is the Smokescreen® Genotyping Array, developed with support from the National Institute on Drug Abuse (NIDA), which provides an end-to-end solution for addiction genetics research. With nearly two decades of collective team experience, BioRealm positions itself as a trusted partner for reproducible and transparent research, operating with HIPAA-compliant standards.

Integrated suite of statistical genetics, bioinformatics, and machine learning methodologies applied to genomic data. Proprietary Smokescreen® Genotyping Array and software for end-to-end addiction genetics research.

BioRealm competes with other boutique bioinformatics consultancies, the in-house analytics teams of large research institutions, and broader contract research organizations (CROs) offering statistical services. For its Smokescreen® array, it competes with large genotyping array providers like Illumina and Thermo Fisher, who offer general-purpose and disease-focused arrays, by offering superior, expert-curated content for a specific niche.